South Korea · Delayed Price · Currency is KRW SG HealthCare Statistics
Total Valuation
SG HealthCare has a market cap or net worth of KRW 257.79 billion. The enterprise value is 261.92 billion.
| Market Cap | 257.79B |
| Enterprise Value | 261.92B |
Important Dates
The next estimated earnings date is Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SG HealthCare has 109.23 million shares outstanding. The number of shares has increased by 23.89% in one year.
| Current Share Class | 109.23M |
| Shares Outstanding | 109.23M |
| Shares Change (YoY) | +23.89% |
| Shares Change (QoQ) | +20.97% |
| Owned by Insiders (%) | 3.14% |
| Owned by Institutions (%) | 0.83% |
| Float | 105.55M |
Valuation Ratios
The trailing PE ratio is 20.47.
| PE Ratio | 20.47 |
| Forward PE | n/a |
| PS Ratio | 9.96 |
| PB Ratio | 9.95 |
| P/TBV Ratio | 10.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 191.94 |
| EV / Sales | 10.12 |
| EV / EBITDA | 99.73 |
| EV / EBIT | 136.47 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.03, with a Debt / Equity ratio of 0.30.
| Current Ratio | 2.03 |
| Quick Ratio | 1.26 |
| Debt / Equity | 0.30 |
| Debt / EBITDA | 2.95 |
| Debt / FCF | -3.13 |
| Interest Coverage | 5.11 |
Financial Efficiency
Return on equity (ROE) is 5.66% and return on invested capital (ROIC) is 5.92%.
| Return on Equity (ROE) | 5.66% |
| Return on Assets (ROA) | 3.37% |
| Return on Invested Capital (ROIC) | 5.92% |
| Return on Capital Employed (ROCE) | 7.19% |
| Weighted Average Cost of Capital (WACC) | 3.17% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.73 |
| Inventory Turnover | 2.61 |
Taxes
In the past 12 months, SG HealthCare has paid 99.34 million in taxes.
| Income Tax | 99.34M |
| Effective Tax Rate | 6.80% |
Stock Price Statistics
The stock price has decreased by -39.56% in the last 52 weeks. The beta is -0.20, so SG HealthCare's price volatility has been lower than the market average.
| Beta (5Y) | -0.20 |
| 52-Week Price Change | -39.56% |
| 50-Day Moving Average | 3,265.60 |
| 200-Day Moving Average | 3,282.23 |
| Relative Strength Index (RSI) | 34.99 |
| Average Volume (20 Days) | 376,143 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SG HealthCare had revenue of KRW 25.88 billion and earned 1.36 billion in profits. Earnings per share was 115.29.
| Revenue | 25.88B |
| Gross Profit | 7.99B |
| Operating Income | 1.92B |
| Pretax Income | 1.46B |
| Net Income | 1.36B |
| EBITDA | 2.63B |
| EBIT | 1.92B |
| Earnings Per Share (EPS) | 115.29 |
Balance Sheet
The company has 4.08 billion in cash and 7.75 billion in debt, with a net cash position of -3.67 billion or -33.62 per share.
| Cash & Cash Equivalents | 4.08B |
| Total Debt | 7.75B |
| Net Cash | -3.67B |
| Net Cash Per Share | -33.62 |
| Equity (Book Value) | 25.90B |
| Book Value Per Share | 1,834.52 |
| Working Capital | 12.84B |
Cash Flow
In the last 12 months, operating cash flow was -884.52 million and capital expenditures -1.59 billion, giving a free cash flow of -2.48 billion.
| Operating Cash Flow | -884.52M |
| Capital Expenditures | -1.59B |
| Depreciation & Amortization | 707.08M |
| Net Borrowing | 2.01B |
| Free Cash Flow | -2.48B |
| FCF Per Share | -22.68 |
Margins
Gross margin is 30.86%, with operating and profit margins of 7.42% and 5.27%.
| Gross Margin | 30.86% |
| Operating Margin | 7.42% |
| Pretax Margin | 5.65% |
| Profit Margin | 5.27% |
| EBITDA Margin | 10.15% |
| EBIT Margin | 7.42% |
| FCF Margin | n/a |
Dividends & Yields
SG HealthCare does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -23.89% |
| Shareholder Yield | -23.89% |
| Earnings Yield | 0.53% |
| FCF Yield | -0.96% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 4, 2024. It was a reverse split with a ratio of 0.3285691.
| Last Split Date | Dec 4, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.3285691 |
Scores
SG HealthCare has an Altman Z-Score of 3.39 and a Piotroski F-Score of 2.
| Altman Z-Score | 3.39 |
| Piotroski F-Score | 2 |